The current status and future perspectives on the successful industrialization of biobased succinic acid are discussed in a comprehensive review article in the peer-reviewed journal Industrial Biotechnology.
Pfizer wants in on Summit’s goal to beat Keytruda via ADC combos
Pfizer wants a piece of the showdown with the world’s biggest medicine. The New York pharma giant — facing an activist investor, shedding multiple parts